Encompass Health Corp (EHC)
ROA
Obliczenia
|
2023/Q4 (31 gru 2023) |
2023/Q3 (30 wrz 2023) |
2023/Q2 (30 cze 2023) |
2023/Q1 (31 mar 2023) |
2022/Q4 (31 gru 2022) |
2022/Q3 (30 wrz 2022) |
2022/Q2 (30 cze 2022) |
2022/Q1 (31 mar 2022) |
||
|---|---|---|---|---|---|---|---|---|---|
| Zysk netto (ttm) | w tys. USD | 349 600 | 351 600 | 312 000 | 269 800 | 269 800 | 272 400 | 326 900 | 391 100 |
| Aktywa razem | w tys. USD | 6 102 400 | 5 964 300 | 5 860 900 | 5 747 300 | 5 636 500 | 5 475 900 | 7 082 200 | 6 944 000 |
| ROA | 5,73% | 5,90% | 5,32% | 4,69% | 4,79% | 4,97% | 4,62% | 5,63% |
2023/Q4 obliczenia
ROA = Zysk netto (ttm) ÷ Aktywa razem
= $349 600K ÷ $6 102 400K
= 5,73%
Analiza porównawcza
2023/Q4
Nazwa spółki
Symbol
ROA
Encompass Health Corp
EHC
5,73%
Acadia Healthcare Company Inc
ACHC
-0,40%
Ensign Group Inc
ENSG
5,01%
HCA Healthcare Inc
HCA
9,33%
National Healthcare Corp.
NHC
5,10%
Pediatrix Medical Group Inc
MD
-2,72%
Select Medical Holdings Corporation
SEM
3,05%
Tenet Healthcare Corp.
THC
2,16%
Universal Health Services, Inc.
UHS
5,14%